Advertisement
Screener

Pelthos Therapeutics Inc. (PTHS) Stock Issued During Period, Value, New Issues

2.9 / 5 stars · 7/12 Roast Me

Pelthos Therapeutics Inc. Stock Issued During Period, Value, New Issues

New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.

  • Pelthos Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2024-03-31 was $5.97M.
  • Pelthos Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $75.60K.
  • Pelthos Therapeutics Inc. stock issued during period, value, new issues for the quarter ending 2023-06-30 was $126.00K.
  • Pelthos Therapeutics Inc. stock issued during period, value, new issues for fiscal 2025 was $38.68M.
  • Pelthos Therapeutics Inc. stock issued during period, value, new issues for fiscal 2023 was $428.40K.
Period endStock Issued During Period, Value, New Issues 3 monthStock Issued During Period, Value, New Issues 12 month
2025-12-31$38.68M
10-K · filed 2026-03-19
2024-03-31$5.97M
10-Q · filed 2025-11-13
2023-12-31$428.40K
10-K · filed 2025-03-27
2023-09-30$75.60K
10-Q · filed 2024-11-13
2023-06-30$126.00K
10-Q · filed 2024-11-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
Atara Biotherapeutics, Inc. (ATRA)United States$0.086B-6.48
COGNITION THERAPEUTICS INC (CGTX)United States$0.090B-6.52
Vaxart, Inc. (VXRT)United States$0.080B3.84
Kalaris Therapeutics, Inc. (KLRS)United States$0.073B-2.19
Cardiff Oncology, Inc. (CRDF)United States$0.101B-2.22
CHAMPIONS ONCOLOGY, INC. (CSBR)United States$0.070B-68.02
BioStem Technologies, Inc. (BSEM)United States$0.069B
Eloxx Pharmaceuticals, Inc. (ELOX)United States$0.065B
Black Diamond Therapeutics, Inc. (BDTX)United States$0.109B-2.48
MiNK Therapeutics, Inc. (INKT)United States$0.063B-5.37